Astringent Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate 952 mg/2299mg; 1347 mg/2299mg Powder, For Solution — NDC 63561-0178-2 (Billing 63561-0178-02)
This is a package of Astringent Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate 952 mg/2299mg; 1347 mg/2299mg Powder, For Solution from Granulation Technology, Inc., first listed with the FDA Jun 2025 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 63561-0178-2 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 63561 labeler · 0178 product · 2 package
- Package marketed since
- Jun 12, 2025
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC)
- 0363561017826
- FDA record last changed
- Aug 27, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1250234
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Drugs for treatment of hyperkalemia and hyperphosphatemia class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
This is an over-the-counter topical powder product that dissolves in water, containing calcium acetate monohydrate and aluminum sulfate tetradecahydrate. Both ingredients function as astringents, which are substances typically used to help dry out and tighten skin or mucous membranes. This type of powder formulation is commonly applied to minor skin irritations, wounds, or areas where reduced moisture and mild tissue contraction are desired. As an OTC monograph drug, it is marketed under FDA guidelines for astringent products.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 63561-0178-02 You're viewing this Main listing | 12 PACKET in 1 CARTON / 2299 mg in 1 PACKET Inner NDC 63561-0178-1 · each packet (2299 mg) | 2023-10-05 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Kerasal Athletes Foot Rapid Symptom Relief Medicated Soak 1347 mg/1; 952 mg 16864-0140-01 | Advantice | 12 powders | — | — | FDA listed | — |
| Domeboro 1347 mg/1; 952 mg 16864-0240-01 | Advantice | 12 powders | — | — | FDA listed | — |
| Astringent 952 mg/2299mg; 1347 mg/2299mgthis 63561-0178-02 | Granulation | 12 packets | — | — | FDA listed | — |
| Astringent Solution 952 mg/2299mg; 1347 mg/2299mg 81469-0999-12 | First | 12 packets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 7CVR7L4A2D
A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
1 inactive ingredient listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Granulation Technology, Inc. labeler code 63561
- Carisoprodol Tablets, USP, 350 mg 350 mg Tablet NDC 63561-0127-1
- Furosemide 20 mg Tablet NDC 63561-0164-1
- Furosemide 40 mg Tablet NDC 63561-0165-1
- Furosemide 80 mg Tablet NDC 63561-0166-1
- Methocarbamol Tablets, USP, 500 mg 500 mg Tablet, Film Coated NDC 63561-0173-1
- Methocarbamol Tablets, USP, 750 mg 750 mg Tablet, Film Coated NDC 63561-0174-1
- Laxative Sennosides, 25 mg 25 mg Tablet, Film Coated NDC 63561-0186-2
- Senna-S DOCUSATE SODIUM, SENNOSIDES 8.6 mg; 50 mg Tablet, Film Coated NDC 63561-0187-1
- Vegetable Laxative SENNOSIDES, 8.6 mg 8.6 mg Tablet, Film Coated NDC 63561-0188-1
- Hyoscyamine Sulfate .125 mg Tablet, Orally Disintegrating NDC 63561-0197-1
- Hyoscyamine Sulfate .125 mg Tablet NDC 63561-0202-1
- Hyoscyamine Sulfate .125 mg Tablet NDC 63561-0203-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses Temporarily relieves minor skin irritations due to: Poison ivy Poison oak Poison sumac Insect bites Athlete's foot Rashes caused by soaps, detergents, cosmetics, or jewelry
⏱️ Dosage and Administration ▾
Directions Dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use. For use as a soak: Soak affected area for 15 to 30 minutes as needed, or as directed by a doctor Repeat 3 times a day or as directed by a doctor Discard solution after each use For use as a compress or wet dressing: Soak a clean, soft cloth in the solution Apply cloth loosely to affected area for 15 to 30 minutes Repeat as needed or as directed by a doctor Discard solution after each use
⚠️ Warnings ▾
Warnings For external use only When using this product Avoid contact with eyes. If contact occurs, rinse thoroughly with water. Do not cover compress or wet dressing with plastic to prevent evaporation In some skin conditions, soaking too long may overdry Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information Protect from excessive heat
🧪 Active Ingredient ▾
Active ingredients (in each packet) Purpose Aluminum sulfate tetradecahydrate, 1347 mg Astringent When combined together in water, these ingredients form the active ingredient aluminum acetate. See Directions. Calcium acetate monohydrate, 952 mg Astringent
🧪 Inactive Ingredients ▾
Inactive ingredients Dextrin
🎯 Purpose ▾
Active ingredients (in each packet) Purpose Aluminum sulfate tetradecahydrate, 1347 mg Astringent When combined together in water, these ingredients form the active ingredient aluminum acetate. See Directions. Calcium acetate monohydrate, 952 mg Astringent
📄 When Using This Product ▾
When using this product Avoid contact with eyes. If contact occurs, rinse thoroughly with water. Do not cover compress or wet dressing with plastic to prevent evaporation In some skin conditions, soaking too long may overdry
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions or comments? 1-973-276-0740
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 2299 mg Packet Carton NDC 63561-0178-02 ALUMINUM SULFATE TETRADECAHYDRATE / CALCIUM ACETATE MONOHYDRATE ASTRINGENT SOLUTION Soothing, Effective Relief of Minor Skin Irritations due to: Poison Ivy Athlete's Foot Insect Bites Rashes Compares to the Active Ingredients in Domeboro ® Granulation Technology, Inc. 12 POWDER PACKETS astringent-carton
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |